0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dalteparin Sodium Injection Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-0F15080
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Dalteparin Sodium Injection Market Research Report 2023
BUY CHAPTERS

Global Dalteparin Sodium Injection Market Research Report 2025

Code: QYRE-Auto-0F15080
Report
May 2025
Pages:71
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dalteparin Sodium Injection Market

The global market for Dalteparin Sodium Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Dalteparin Sodium Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Dalteparin Sodium Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Dalteparin Sodium Injection include Pfizer, Hebei Changshan Biochemical Pharmaceutical Co.,Ltd., Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd., Changzhou Qianhong Biopharma Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dalteparin Sodium Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dalteparin Sodium Injection.
The Dalteparin Sodium Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dalteparin Sodium Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dalteparin Sodium Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Dalteparin Sodium Injection Market Report

Report Metric Details
Report Name Dalteparin Sodium Injection Market
Segment by Type
  • 0.3ml:7500AⅩaIU
  • 0.2ml:2500IU
  • 0.2ml:5000IU
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Hebei Changshan Biochemical Pharmaceutical Co.,Ltd., Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd., Changzhou Qianhong Biopharma Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Dalteparin Sodium Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Dalteparin Sodium Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Dalteparin Sodium Injection Market report?

Ans: The main players in the Dalteparin Sodium Injection Market are Pfizer, Hebei Changshan Biochemical Pharmaceutical Co.,Ltd., Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd., Changzhou Qianhong Biopharma Co., Ltd.

What are the Application segmentation covered in the Dalteparin Sodium Injection Market report?

Ans: The Applications covered in the Dalteparin Sodium Injection Market report are Hospital, Nursing Institutions, Home Care, Others

What are the Type segmentation covered in the Dalteparin Sodium Injection Market report?

Ans: The Types covered in the Dalteparin Sodium Injection Market report are 0.3ml:7500AⅩaIU, 0.2ml:2500IU, 0.2ml:5000IU

Recommended Reports

Sodium Injection Markets

API Sodium Markets

Heparin Related Markets

1 Dalteparin Sodium Injection Market Overview
1.1 Product Definition
1.2 Dalteparin Sodium Injection by Type
1.2.1 Global Dalteparin Sodium Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 0.3ml:7500AⅩaIU
1.2.3 0.2ml:2500IU
1.2.4 0.2ml:5000IU
1.3 Dalteparin Sodium Injection by Application
1.3.1 Global Dalteparin Sodium Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Nursing Institutions
1.3.4 Home Care
1.3.5 Others
1.4 Global Dalteparin Sodium Injection Market Size Estimates and Forecasts
1.4.1 Global Dalteparin Sodium Injection Revenue 2020-2031
1.4.2 Global Dalteparin Sodium Injection Sales 2020-2031
1.4.3 Global Dalteparin Sodium Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Dalteparin Sodium Injection Market Competition by Manufacturers
2.1 Global Dalteparin Sodium Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Dalteparin Sodium Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Dalteparin Sodium Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Dalteparin Sodium Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dalteparin Sodium Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dalteparin Sodium Injection, Product Type & Application
2.7 Global Key Manufacturers of Dalteparin Sodium Injection, Date of Enter into This Industry
2.8 Global Dalteparin Sodium Injection Market Competitive Situation and Trends
2.8.1 Global Dalteparin Sodium Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Dalteparin Sodium Injection Players Market Share by Revenue
2.8.3 Global Dalteparin Sodium Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dalteparin Sodium Injection Market Scenario by Region
3.1 Global Dalteparin Sodium Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Dalteparin Sodium Injection Sales by Region: 2020-2031
3.2.1 Global Dalteparin Sodium Injection Sales by Region: 2020-2025
3.2.2 Global Dalteparin Sodium Injection Sales by Region: 2026-2031
3.3 Global Dalteparin Sodium Injection Revenue by Region: 2020-2031
3.3.1 Global Dalteparin Sodium Injection Revenue by Region: 2020-2025
3.3.2 Global Dalteparin Sodium Injection Revenue by Region: 2026-2031
3.4 North America Dalteparin Sodium Injection Market Facts & Figures by Country
3.4.1 North America Dalteparin Sodium Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Dalteparin Sodium Injection Sales by Country (2020-2031)
3.4.3 North America Dalteparin Sodium Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dalteparin Sodium Injection Market Facts & Figures by Country
3.5.1 Europe Dalteparin Sodium Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Dalteparin Sodium Injection Sales by Country (2020-2031)
3.5.3 Europe Dalteparin Sodium Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dalteparin Sodium Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Dalteparin Sodium Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Dalteparin Sodium Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Dalteparin Sodium Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Dalteparin Sodium Injection Market Facts & Figures by Country
3.7.1 Latin America Dalteparin Sodium Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Dalteparin Sodium Injection Sales by Country (2020-2031)
3.7.3 Latin America Dalteparin Sodium Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dalteparin Sodium Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Dalteparin Sodium Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Dalteparin Sodium Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Dalteparin Sodium Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dalteparin Sodium Injection Sales by Type (2020-2031)
4.1.1 Global Dalteparin Sodium Injection Sales by Type (2020-2025)
4.1.2 Global Dalteparin Sodium Injection Sales by Type (2026-2031)
4.1.3 Global Dalteparin Sodium Injection Sales Market Share by Type (2020-2031)
4.2 Global Dalteparin Sodium Injection Revenue by Type (2020-2031)
4.2.1 Global Dalteparin Sodium Injection Revenue by Type (2020-2025)
4.2.2 Global Dalteparin Sodium Injection Revenue by Type (2026-2031)
4.2.3 Global Dalteparin Sodium Injection Revenue Market Share by Type (2020-2031)
4.3 Global Dalteparin Sodium Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Dalteparin Sodium Injection Sales by Application (2020-2031)
5.1.1 Global Dalteparin Sodium Injection Sales by Application (2020-2025)
5.1.2 Global Dalteparin Sodium Injection Sales by Application (2026-2031)
5.1.3 Global Dalteparin Sodium Injection Sales Market Share by Application (2020-2031)
5.2 Global Dalteparin Sodium Injection Revenue by Application (2020-2031)
5.2.1 Global Dalteparin Sodium Injection Revenue by Application (2020-2025)
5.2.2 Global Dalteparin Sodium Injection Revenue by Application (2026-2031)
5.2.3 Global Dalteparin Sodium Injection Revenue Market Share by Application (2020-2031)
5.3 Global Dalteparin Sodium Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Dalteparin Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Dalteparin Sodium Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd.
6.2.1 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Company Information
6.2.2 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Description and Business Overview
6.2.3 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Dalteparin Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Dalteparin Sodium Injection Product Portfolio
6.2.5 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.3 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
6.3.1 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Company Information
6.3.2 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Dalteparin Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Dalteparin Sodium Injection Product Portfolio
6.3.5 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Changzhou Qianhong Biopharma Co., Ltd.
6.4.1 Changzhou Qianhong Biopharma Co., Ltd. Company Information
6.4.2 Changzhou Qianhong Biopharma Co., Ltd. Description and Business Overview
6.4.3 Changzhou Qianhong Biopharma Co., Ltd. Dalteparin Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Changzhou Qianhong Biopharma Co., Ltd. Dalteparin Sodium Injection Product Portfolio
6.4.5 Changzhou Qianhong Biopharma Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dalteparin Sodium Injection Industry Chain Analysis
7.2 Dalteparin Sodium Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dalteparin Sodium Injection Production Mode & Process Analysis
7.4 Dalteparin Sodium Injection Sales and Marketing
7.4.1 Dalteparin Sodium Injection Sales Channels
7.4.2 Dalteparin Sodium Injection Distributors
7.5 Dalteparin Sodium Injection Customer Analysis
8 Dalteparin Sodium Injection Market Dynamics
8.1 Dalteparin Sodium Injection Industry Trends
8.2 Dalteparin Sodium Injection Market Drivers
8.3 Dalteparin Sodium Injection Market Challenges
8.4 Dalteparin Sodium Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Dalteparin Sodium Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Dalteparin Sodium Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Dalteparin Sodium Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Dalteparin Sodium Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Dalteparin Sodium Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Dalteparin Sodium Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Dalteparin Sodium Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Dalteparin Sodium Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Dalteparin Sodium Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Dalteparin Sodium Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Dalteparin Sodium Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Dalteparin Sodium Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Dalteparin Sodium Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dalteparin Sodium Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Dalteparin Sodium Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Dalteparin Sodium Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Dalteparin Sodium Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Dalteparin Sodium Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Dalteparin Sodium Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Dalteparin Sodium Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Dalteparin Sodium Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Dalteparin Sodium Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Dalteparin Sodium Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Dalteparin Sodium Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Dalteparin Sodium Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Dalteparin Sodium Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Dalteparin Sodium Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Dalteparin Sodium Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Dalteparin Sodium Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Dalteparin Sodium Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Dalteparin Sodium Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Dalteparin Sodium Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Dalteparin Sodium Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Dalteparin Sodium Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Dalteparin Sodium Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Dalteparin Sodium Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Dalteparin Sodium Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Dalteparin Sodium Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Dalteparin Sodium Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Dalteparin Sodium Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Dalteparin Sodium Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Dalteparin Sodium Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Dalteparin Sodium Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Dalteparin Sodium Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Dalteparin Sodium Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Dalteparin Sodium Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Dalteparin Sodium Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Dalteparin Sodium Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Dalteparin Sodium Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Dalteparin Sodium Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Dalteparin Sodium Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Dalteparin Sodium Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Dalteparin Sodium Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Dalteparin Sodium Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Dalteparin Sodium Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Dalteparin Sodium Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Dalteparin Sodium Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Dalteparin Sodium Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Dalteparin Sodium Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Dalteparin Sodium Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Dalteparin Sodium Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Dalteparin Sodium Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Dalteparin Sodium Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Dalteparin Sodium Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Dalteparin Sodium Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Dalteparin Sodium Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Dalteparin Sodium Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Dalteparin Sodium Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Dalteparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Dalteparin Sodium Injection Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Company Information
 Table 76. Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Description and Business Overview
 Table 77. Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Dalteparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Dalteparin Sodium Injection Product
 Table 79. Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Recent Developments/Updates
 Table 80. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Company Information
 Table 81. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Description and Business Overview
 Table 82. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Dalteparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Dalteparin Sodium Injection Product
 Table 84. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 85. Changzhou Qianhong Biopharma Co., Ltd. Company Information
 Table 86. Changzhou Qianhong Biopharma Co., Ltd. Description and Business Overview
 Table 87. Changzhou Qianhong Biopharma Co., Ltd. Dalteparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Changzhou Qianhong Biopharma Co., Ltd. Dalteparin Sodium Injection Product
 Table 89. Changzhou Qianhong Biopharma Co., Ltd. Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. Dalteparin Sodium Injection Distributors List
 Table 93. Dalteparin Sodium Injection Customers List
 Table 94. Dalteparin Sodium Injection Market Trends
 Table 95. Dalteparin Sodium Injection Market Drivers
 Table 96. Dalteparin Sodium Injection Market Challenges
 Table 97. Dalteparin Sodium Injection Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Dalteparin Sodium Injection
 Figure 2. Global Dalteparin Sodium Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Dalteparin Sodium Injection Market Share by Type: 2024 & 2031
 Figure 4. 0.3ml:7500AⅩaIU Product Picture
 Figure 5. 0.2ml:2500IU Product Picture
 Figure 6. 0.2ml:5000IU Product Picture
 Figure 7. Global Dalteparin Sodium Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Dalteparin Sodium Injection Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Nursing Institutions
 Figure 11. Home Care
 Figure 12. Others
 Figure 13. Global Dalteparin Sodium Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Dalteparin Sodium Injection Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Dalteparin Sodium Injection Sales (2020-2031) & (K Units)
 Figure 16. Global Dalteparin Sodium Injection Average Price (US$/Unit) & (2020-2031)
 Figure 17. Dalteparin Sodium Injection Report Years Considered
 Figure 18. Dalteparin Sodium Injection Sales Share by Manufacturers in 2024
 Figure 19. Global Dalteparin Sodium Injection Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Dalteparin Sodium Injection Players: Market Share by Revenue in Dalteparin Sodium Injection in 2024
 Figure 21. Dalteparin Sodium Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Dalteparin Sodium Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Dalteparin Sodium Injection Sales Market Share by Country (2020-2031)
 Figure 24. North America Dalteparin Sodium Injection Revenue Market Share by Country (2020-2031)
 Figure 25. United States Dalteparin Sodium Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Dalteparin Sodium Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Dalteparin Sodium Injection Sales Market Share by Country (2020-2031)
 Figure 28. Europe Dalteparin Sodium Injection Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Dalteparin Sodium Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Dalteparin Sodium Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Dalteparin Sodium Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Dalteparin Sodium Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Dalteparin Sodium Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Dalteparin Sodium Injection Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Dalteparin Sodium Injection Revenue Market Share by Region (2020-2031)
 Figure 36. China Dalteparin Sodium Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Dalteparin Sodium Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Dalteparin Sodium Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Dalteparin Sodium Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Dalteparin Sodium Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Dalteparin Sodium Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Dalteparin Sodium Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Dalteparin Sodium Injection Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Dalteparin Sodium Injection Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Dalteparin Sodium Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Dalteparin Sodium Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Dalteparin Sodium Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Dalteparin Sodium Injection Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Dalteparin Sodium Injection Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Dalteparin Sodium Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Dalteparin Sodium Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Dalteparin Sodium Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Dalteparin Sodium Injection by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Dalteparin Sodium Injection by Type (2020-2031)
 Figure 55. Global Dalteparin Sodium Injection Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Dalteparin Sodium Injection by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Dalteparin Sodium Injection by Application (2020-2031)
 Figure 58. Global Dalteparin Sodium Injection Price (US$/Unit) by Application (2020-2031)
 Figure 59. Dalteparin Sodium Injection Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String